FDA Adverse Event Injury Summary report: N

ACRYSOF

MDR report key: 2930390 · Received January 22, 2013

Report

Report Number
1119421-2013-00062
Event Type
Injury
Date Received
January 22, 2013
Date of Event
January 1, 2012
Report Date
December 24, 2012
Manufacturer
ALCON RESEARCH, LTD. / HUNTINGTON
Product Code
HQL
PMA / PMN Number
P930014
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

EVAL SUMMARY: THE PRODUCT WAS NOT RETURNED FOR ANALYSIS. PRODUCT HISTORY RECORDS COULD NOT BE REVIEWED BECAUSE THE REPORTING FACILITY DID NOT PROVIDE A LOT NUMBER OR ANY IDENTIFICATION TRACEABLE TO THE MFG DOCUMENTATION. THE PRODUCT WAS NOT RETURNED AND NOT ENOUGH INFO WAS PROVIDED FROM THE ACCOUNT TO PROPERLY COMPLETE AN INVESTIGATION. PENG C, ZHAO J, MA L, QU B, SUN Q, ZHANG J. OPTICAL PERFORMANCE AFTER BILATERAL IMPLANTATION OF APODIZED ASPHERIC DIFFRACTIVE MULTIFOCAL INTRAOCULAR LENSES WITH +3.00-D ADDITION POWER. ACTA OPHTHALMOLOGICA SCANDINAVICA FOUNDATION; 2012; 90: E586-E593. (B)(4).

Description of Event or Problem · 1

A JOURNAL ARTICLE REPORTED THE RESULTS OF A STUDY THAT COMPARED THE VISUAL AND OPTICAL PERFORMANCE OF MULTIFOCAL INTRAOCULAR LENSES (IOLS) WITH THE STANDARD ASPHERIC MONOFOCAL IOLS, WHEN IMPLANTED BILATERALLY. THE ARTICLE STATES THAT THE FOLLOWING VISUAL DISTURBANCES WERE REPORTED BY PTS IN BOTH GROUPS: GLARE/FLARE, PROBLEMS WITH NIGHT VISION, HALOS, DISTORTED NEAR VISION, DISTORTED FAR VISION, BLURRED NEAR VISION, BLURRED FAR VISION, PROBLEMS WITH COLOR VISION, AND DOUBLE VISION WITH BOTH EYES. ADD¿L INFO WAS REQUESTED; HOWEVER, THE SURGEON WAS UNABLE TO PROVIDE FURTHER DETAILS. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS EVENT. THIS REPORT IS FOR THE PTS IN THE MONOFOCAL IOL GROUP.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
30290 ACRYSOF INTRAOCULAR LENS HQL ALCON RESEARCH, LTD. / HUNTINGTON SN60WF UNK

Patients

Seq Age Sex Outcome Treatment
1 Other